| P2093 | author name string | John H Chang | |
| | Peter J McCluskey | |
| P2860 | cites work | Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid | Q70287560 |
| | Benign mucous membrane pemphigoid | Q70601259 |
| | The immunological features and pathophysiology of ocular cicatricial pemphigoid | Q72798992 |
| | Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid | Q73211528 |
| | Methotrexate therapy for ocular cicatricial pemphigoid | Q79839729 |
| | The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators | Q34570285 |
| | Mucous membrane pemphigoid and pseudopemphigoid | Q35623517 |
| | Dapsone therapy for the acute inflammatory phase of ocular pemphigoid | Q37297613 |
| | Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid | Q37311216 |
| | Progression of disease in ocular cicatricial pemphigoid | Q37319447 |
| | Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid | Q37321480 |
| | Treatment of ocular cicatricial pemphigoid with sulfasalazine | Q43727791 |
| | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid | Q43842999 |
| | Medial canthal keratinisation (MCK): a diagnostic sign of ocular cicatricial pemphigoid | Q44219204 |
| | Low-dose methotrexate therapy for ocular inflammatory disease | Q45693995 |
| | Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up | Q47247986 |
| | A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. | Q47381459 |
| | Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. | Q54071658 |
| | The Acute Manifestations of Ocular Cicatricial Pemphigoid: Diagnosis and Treatment | Q66994631 |
| | Improved detection of disease progression in ocular cicatricial pemphigoid | Q67574625 |
| | Cicatricial pemphigoid | Q68158346 |
| | On the so-called ocular pemphigus (pemphigus ocularis, pemphigus conjunctivae) | Q69164611 |
| | Efficacy of low-dose methotrexate in rheumatoid arthritis | Q69884411 |
| | Ocular cicatricial pemphigoid | Q70149761 |
| | Systemic chemotherapy for ocular cicatricial pemphigoid | Q70198195 |
| | Immunosuppressive therapy for progressive ocular cicatricial pemphigoid | Q70249115 |
| P433 | issue | 4 | |
| P921 | main subject | cicatricial pemphigoid | Q627291 |
| P304 | page(s) | 333-338 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Current Allergy and Asthma Reports | Q2246111 |
| P1476 | title | Ocular cicatricial pemphigoid: manifestations and management | |
| P478 | volume | 5 | |